FDA OKs Trials for Nexalin's Sleep and Anxiety Therapy Headset
The FDA has agreed on the design for Nexalin's planned clinical studies of the Gen-3 HALO Clarity, targeting insomnia and anxiety.
Source: sleepreviewmag.com
Stay updated with breaking news from Studies Set. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA has agreed on the design for Nexalin's planned clinical studies of the Gen-3 HALO Clarity, targeting insomnia and anxiety.